Interventional Oncology Market - Global Forecast 2026-2032

The interventional oncology market is undergoing significant transformation as the sector adopts minimally invasive, image-guided approaches that enhance patient care and operational efficiency. Senior healthcare leaders are focusing on technology integration, data-driven decision-making, and strategic partnerships to maintain market agility and capture value amid ongoing innovation.

Market Snapshot: Interventional Oncology Market Size, Growth, and Outlook

The interventional oncology market is projected to expand from USD 2.73 billion in 2025 to USD 2.93 billion in 2026, reaching USD 4.58 billion by 2032, driven by a compound annual growth rate of 7.65%. This advancement is attributed to the increasing preference for targeted, minimally invasive therapies across acute and outpatient care. Integration of advanced technologies, evolving reimbursement protocols, and optimized workflows are influencing competitive strategy, enabling both manufacturers and providers to respond efficiently to emerging care models and operational imperatives.

Scope & Segmentation Across Modalities, Indications, Technologies, and Regions

This analysis dissects the interventional oncology landscape, offering granular segmentation and highlighting the diverse dynamics affecting product design and market adoption. Strategic differentiation is achieved through attention to clinical, operational, and commercial factors shaping industry priorities.

Product Modalities: Incorporates ablation devices such as cryoablation, high-intensity focused ultrasound, and laser systems; embolization devices like drug-eluting beads and microspheres; and ancillary systems, including guidewires and introduction kits, to accommodate varying procedural approaches and clinical requirements.
Tumor Indications: Encompasses interventions for colorectal, kidney, liver, and lung cancers, each presenting distinct clinical pathways and device modality considerations. Implementation often requires multidisciplinary coordination to ensure optimal outcomes and device alignment.
Technology Types: Spans brachytherapy, image-guided radiotherapy, microwave ablation, and radiofrequency ablation, all of which support unique procedural workflows and require investment in specialized platforms.
End-User Settings: Accounts for ambulatory surgical centers, cancer research institutes, and hospitals. Variability in operational structures across these settings impacts procurement preferences, clinical adoption, and workflow integration.
Regional Scope: Covers the Americas, Europe, Middle East & Africa, and Asia-Pacific. Each region demonstrates differences in regulatory landscape, infrastructure readiness, and adoption trajectory, affecting both accessibility and market scalability for stakeholders.

Key Takeaways for Senior Decision-Makers

Demand is building for modular, interoperable platforms that complement existing clinical workflows and facilitate expansion into outpatient and ambulatory care environments.
Collaboration between manufacturers, healthcare systems, and clinical teams enables bundled product offerings, speeds evidence generation, and improves training, supporting efficient market penetration.
Emphasis on comparative effectiveness and real-world evidence by payers and regulators is guiding investment in data-driven registry strategies and robust post-market surveillance.
Cancer type, technology selection, and care setting require tailored go-to-market strategies to maximize product impact and drive differentiated commercialization.
Outcome-based contracting models, including flexible service agreements and remote support, are reducing adoption barriers and creating additional value for provider organizations managing resource pressures.
Proactive diversification of suppliers and supply chain adjustments are necessary to safeguard business continuity and sustain reliable delivery amid global disruptions.

Tariff Impact: Navigating Trade Policy Shifts Across the Value Chain

Recent U.S. tariff adjustments have created pronounced effects on the interventional oncology value chain, influencing both component sourcing and cost management for industry participants. Manufacturers have mitigated these impacts by broadening supplier networks, increasing reliance on domestic production, and restructuring supply chains to ensure consistent service levels and address pricing challenges. Healthcare organizations have in turn responded by adapting procurement practices, emphasizing solutions that streamline operations and reduce procedural risks, often leveraging integrated agreements and strategic partnerships to maintain operational readiness during periods of policy change.

Methodology & Data Sources

Qualitative interviews with clinicians, engineers, and procurement executives form the primary evidence base for this report. Supplementary analyses of clinical guidelines, regulatory filings, and manufacturer documentation enhance reliability. A triangulation method ensures that findings correspond with published sector data and observed real-world results.

Why This Report Matters

Helps executive leaders benchmark organizational positioning, assess commercial and operational risks, and prioritize investments in the interventional oncology space.
Delivers focused, actionable insights into innovation management, reimbursement optimization, and supply chain resilience to inform forward-looking strategy.
Equips companies to refine data strategy, streamline commercialization processes, and adapt to changing market demands for sustained success.

Conclusion

As clinical advancements, operational demands, and policies continue to reshape interventional oncology, organizations that align technology, data, and strategic partnerships will secure growth and resilience in a competitive environment.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Interventional Oncology Market, by Product

8.1. Ablation Devices
8.1.1. Cryoablation Devices
8.1.2. High-Intensity Focused Ultrasound
8.1.3. Laser Systems
8.2. Embolization Devices
8.2.1. Drug-Eluting Beads
8.2.2. Microspheres
8.3. Supportive Devices
8.3.1. Guidewires
8.3.2. Introduction Kits

9. Interventional Oncology Market, by Cancer Type

9.1. Colorectal Cancer
9.2. Kidney Cancer
9.3. Liver Cancer
9.4. Lung Cancer

10. Interventional Oncology Market, by Technology

10.1. Brachytherapy
10.2. Image-Guided Radiotherapy
10.3. Microwave Ablation
10.4. Radiofrequency Ablation

11. Interventional Oncology Market, by End-User

11.1. Ambulatory Surgical Centers
11.2. Cancer Research Institutes
11.3. Hospitals

12. Interventional Oncology Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Interventional Oncology Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Interventional Oncology Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Interventional Oncology Market
16. China Interventional Oncology Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. ABK Biomedical Inc.
17.7. Accuray Incorporated
17.8. AngioDynamics, Inc.
17.9. Bayer AG
17.10. Becton, Dickinson and Company
17.11. Boston Scientific Corporation
17.12. Cook Group Incorporated
17.13. Eckert & Ziegler BEBIG AG
17.14. Fujifilm Holdings Corporation
17.15. GE HealthCare Technologies Inc.
17.16. IceCure Medical Ltd.
17.17. Integer Holding Corporation
17.18. Johnson & Johnson Services, Inc.
17.19. Koninklijke Philips N.V.
17.20. Medtronic PLC
17.21. Merit Medical Systems, Inc.
17.22. Siemens Healthineers AG
17.23. Sirtex Medical Limited
17.24. Sonablate Corp
17.25. STARmed Co., Ltd.
17.26. Stryker Corporation
17.27. Surgnova Healthcare Technologies (Zhejiang) Co., Ltd.
17.28. Teleflex Incorporated
17.29. Terumo Corporation

List of Figures

FIGURE 1. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CRYOABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CRYOABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CRYOABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LASER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LASER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY DRUG-ELUTING BEADS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY DRUG-ELUTING BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROSPHERES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROSPHERES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY INTRODUCTION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY INTRODUCTION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY INTRODUCTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROWAVE ABLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROWAVE ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 105. EUROPE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. EUROPE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 107. EUROPE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 108. EUROPE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 109. EUROPE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 110. EUROPE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 111. EUROPE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 112. EUROPE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 121. AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 123. AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 124. AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 125. AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 126. AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 127. AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 128. AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. ASEAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. ASEAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 140. ASEAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 141. ASEAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 142. ASEAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 143. ASEAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 144. ASEAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. ASEAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 146. GCC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GCC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 148. GCC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 149. GCC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 150. GCC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 151. GCC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 152. GCC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. GCC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 162. BRICS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. BRICS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 164. BRICS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 165. BRICS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 166. BRICS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 167. BRICS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 168. BRICS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. BRICS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 170. G7 INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. G7 INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 172. G7 INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 173. G7 INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 174. G7 INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 175. G7 INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 176. G7 INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 177. G7 INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 178. NATO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. NATO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 180. NATO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 181. NATO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 182. NATO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 183. NATO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 184. NATO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. NATO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 195. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 196. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 197. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 198. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2032 (USD MILLION)
TABLE 199. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 200. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 201. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 202. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Interventional Oncology market report include:

Abbott Laboratories
ABK Biomedical Inc.
Accuray Incorporated
AngioDynamics, Inc.
Bayer AG
Becton, Dickinson and Company
Boston Scientific Corporation
Cook Group Incorporated
Eckert & Ziegler BEBIG AG
Fujifilm Holdings Corporation
GE HealthCare Technologies Inc.
IceCure Medical Ltd.
Integer Holding Corporation
Johnson & Johnson Services, Inc.
Koninklijke Philips N.V.
Medtronic PLC
Merit Medical Systems, Inc.
Siemens Healthineers AG
Sirtex Medical Limited
Sonablate Corp
STARmed Co., Ltd.
Stryker Corporation
Surgnova Healthcare Technologies (Zhejiang) Co., Ltd.
Teleflex Incorporated
Terumo Corporation

Table Information

Report Attribute	Details
No. of Pages	196
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.93 Billion
Forecasted Market Value ( USD ) by 2032	$ 4.58 Billion
Compound Annual Growth Rate	7.6%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3471EUR$3,939USD£3,022GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3745EUR$4,249USD£3,259GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5075EUR$5,759USD£4,418GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6142EUR$6,969USD£5,346GBP

Market Snapshot: Interventional Oncology Market Size, Growth, and Outlook

Scope & Segmentation Across Modalities, Indications, Technologies, and Regions

Key Takeaways for Senior Decision-Makers

Tariff Impact: Navigating Trade Policy Shifts Across the Value Chain

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Interventional Oncology Market Report 2025

Interventional Oncology Market by Devices & Consumables (RF, Microwave, Cryoablation. Embolization), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung), End User (Hospital, Specialty Clinic) - Global Forecast to 2029

Interventional Oncology Ablation Market - Global Strategic Business Report

Interventional Oncology Market Size, Share & Trends Analysis Report by Technique, Procedures, Application, End-use, and Region with Growth Forecasts, 2026-2033

Interventional Oncology Devices - Global Strategic Business Report